70
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis

, , &
Pages 55-60 | Published online: 22 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Feng Xie, Robert B. Hopkins, Natasha Burke, Mohdhar Habib, Carlo De Angelis, Mark Pasetka, Angie Giotis & Ron Goeree. (2014) Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study. Hospital Practice 42:2, pages 38-45.
Read now
Mohdhar J. Habib, Tazmin Merali, Allan Mills & Visal Uon. (2014) Canadian Health Care Institution Resource Utilization Resulting From Skeletal-Related Events. Hospital Practice 42:1, pages 15-22.
Read now
Louis S Matza, Ze Cong, Karen Chung, Alison Stopeck, Katia Tonkin, Janet Brown, Ada Braun, Kate Van Brunt & Kelly McDaniel. (2013) Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases. Patient Preference and Adherence 7, pages 855-865.
Read now
Allan Lipton & Arun Balakumaran. (2012) Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors. Expert Review of Clinical Pharmacology 5:4, pages 359-371.
Read now